Back
Corporate News
Shilpa Medicare appoints Dr. Uday Harle CEO of its subsidiary, Shilpa Biologicals
03-Aug-2026, 11:00
Shilpa Medicare Limited announced the appointment of Dr. Uday N. Harle as Chief Executive Officer of its wholly owned subsidiary, Shilpa Biologicals Private Limited, effective August 3, 2026. Dr. Harle, who most recently served as Chief Business Officer at Artemis Medicare Services Limited and Premedium Pharma (Apollo Group), brings approximately 24 years of experience in the biopharmaceutical industry, including expertise in biologics, biosimilars, and regulatory affairs.
Shilpa Medicare Limited announced the appointment of Dr. Uday N. Harle as Chief Executive Officer of its wholly owned subsidiary, Shilpa Biologicals Private Limited, effective August 3, 2026. Dr. Harle, who most recently served as Chief Business Officer at Artemis Medicare Services Limited and Premedium Pharma (Apollo Group), brings approximately 24 years of experience in the biopharmaceutical industry, including expertise in biologics, biosimilars, and regulatory affairs.